CUPRYMINA

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Poland.

Active ingredients

The drug CUPRYMINA contains one active pharmaceutical ingredient (API):

1	Copper ⁶⁴Cu chloride UNII 3IGV2Y2378 - CUPRIC CHLORIDE ANHYDROUS CU-64
	Copper-64 chloride is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal product must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.
	Read more about Copper ⁶⁴Cu chloride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CUPRYMINA Radiopharmaceutical precursor, solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09XX	Various diagnostic radiopharmaceuticals	V Various → V09 Diagnostic radiopharmaceuticals → V09X Other diagnostic radiopharmaceuticals
Discover more medicines within V09XX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1592984
PL	Rejestru Produktów Leczniczych	100309349